Multicenter Dispensing Study of Biofinity Toric Made-To-Order Lenses in Extended Power Ranges

NCT ID: NCT02193178

Last Updated: 2020-07-29

Study Results

Results available

Outcome measurements, participant flow, baseline characteristics, and adverse events have been published for this study.

View full results

Basic Information

Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.

Recruitment Status

COMPLETED

Clinical Phase

NA

Total Enrollment

15 participants

Study Classification

INTERVENTIONAL

Study Start Date

2014-07-31

Study Completion Date

2016-04-30

Brief Summary

Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.

The study hypothesis is that the Biofinity Toric XR lenses will perform as well as or better than the participants' habitual contact lenses.

Detailed Description

Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.

The study hypothesis is that the Biofinity Toric XR lenses will perform as well as or better than the participants' habitual contact lenses. Further, that a minimum of 80% of those enrolled will complete 2 weeks of lens wear with no contraindication to continue.

Conditions

See the medical conditions and disease areas that this research is targeting or investigating.

Myopia Astigmatism

Study Design

Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.

Allocation Method

NA

Intervention Model

SINGLE_GROUP

Primary Study Purpose

TREATMENT

Blinding Strategy

NONE

Study Groups

Review each arm or cohort in the study, along with the interventions and objectives associated with them.

comfilcon A toric

Participants are habitual toric lens wearers and will be fitted with comfilcon A toric lenses.

Group Type EXPERIMENTAL

comfilcon A Toric

Intervention Type DEVICE

Contact lenses

Interventions

Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.

comfilcon A Toric

Contact lenses

Intervention Type DEVICE

Other Intervention Names

Discover alternative or legacy names that may be used to describe the listed interventions across different sources.

Biofinity

Eligibility Criteria

Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.

Inclusion Criteria

* Has had an oculo-visual examination in the last two years
* Is at least 18 years of age and has full legal capacity to volunteer
* Has read and understood the information consent letter
* Is willing and able to follow instructions and maintain the appointment schedule
* Is correctable to a visual acuity of 20/50 or better (in at least one eye)
* Currently wears soft toric contact lenses in both eyes
* Subject contact lens prescription must fall under one of the contact lens power ranges for at least one eye:

* -20.00D to -10.50D spherical powers and cylinder powers from - 0.75 to -2.25
* +8.50D to +20.00D spherical powers and cylinder powers from - 0.75 to -2.25
* -20.00D to -6.50D spherical powers and cylinder powers from -2.75 to -5.75
* -6.00D to +6.00D spherical powers and cylinder powers from -2.75 to -5.75
* +6.50D to +20.00D spherical powers and cylinder powers from-2.75 to -5.75
* Has clear corneas and no active ocular disease
* Demonstrates an acceptable fit with the study lenses

Exclusion Criteria

* Has never worn contact lenses before;
* Has any systemic disease affecting ocular health;
* Is using any systemic or topical medications that will affect ocular health;
* Has any ocular pathology or abnormality that would affect the wearing of contact lenses;
* Has undergone corneal refractive surgery;
* Is participating in any other type of eye related clinical or research study.
Minimum Eligible Age

18 Years

Eligible Sex

ALL

Accepts Healthy Volunteers

No

Sponsors

Meet the organizations funding or collaborating on the study and learn about their roles.

CooperVision, Inc.

INDUSTRY

Sponsor Role lead

Responsible Party

Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.

Responsibility Role SPONSOR

Principal Investigators

Learn about the lead researchers overseeing the trial and their institutional affiliations.

Jan Bergmanson, OD PhD

Role: PRINCIPAL_INVESTIGATOR

Texas Eye Research and Technology Center (TERTC), School of Optometry, University of Houston

Pete Kollbaum, OD PhD

Role: PRINCIPAL_INVESTIGATOR

Clinical Optics Research Lab (CORL), Indiana University School of Optometry, Indiana University

Locations

Explore where the study is taking place and check the recruitment status at each participating site.

Clinical Optics Research Lab (CORL) Indiana University School of Optometry, Indiana University

Bloomington, Indiana, United States

Site Status

Texas Eye Research and Technology Center (TERTC) College of Optometry, University of Houston

Houston, Texas, United States

Site Status

Countries

Review the countries where the study has at least one active or historical site.

United States

Other Identifiers

Review additional registry numbers or institutional identifiers associated with this trial.

CV-14-05

Identifier Type: -

Identifier Source: org_study_id

More Related Trials

Additional clinical trials that may be relevant based on similarity analysis.